000287296 001__ 287296
000287296 005__ 20250415112709.0
000287296 0247_ $$2doi$$a10.1038/s41698-024-00500-5
000287296 0247_ $$2pmid$$apmid:38273014
000287296 0247_ $$2altmetric$$aaltmetric:158876515
000287296 037__ $$aDKFZ-2024-00216
000287296 041__ $$aEnglish
000287296 082__ $$a610
000287296 1001_ $$0P:(DE-He78)be724b82903aa397737196d8200edb30$$aWang, Changwen$$b0$$eFirst author$$udkfz
000287296 245__ $$aA multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs.
000287296 260__ $$a[London]$$bSpringer Nature$$c2024
000287296 3367_ $$2DRIVER$$aarticle
000287296 3367_ $$2DataCite$$aOutput Types/Journal article
000287296 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1706532584_23420
000287296 3367_ $$2BibTeX$$aARTICLE
000287296 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000287296 3367_ $$00$$2EndNote$$aJournal Article
000287296 500__ $$aDKFZ-ZMBH alliance / #EA:A240#LA:A240#
000287296 520__ $$aRecent advances in the genomics of glioblastoma (GBM) led to the introduction of molecular neuropathology but failed to translate into treatment improvement. This is largely attributed to the genetic and phenotypic heterogeneity of GBM, which are considered the major obstacle to GBM therapy. Here, we use advanced human GBM-like organoid (LEGO: Laboratory Engineered Glioblastoma-like Organoid) models and provide an unprecedented comprehensive characterization of LEGO models using single-cell transcriptome, DNA methylome, metabolome, lipidome, proteome, and phospho-proteome analysis. We discovered that genetic heterogeneity dictates functional heterogeneity across molecular layers and demonstrates that NF1 mutation drives mesenchymal signature. Most importantly, we found that glycerol lipid reprogramming is a hallmark of GBM, and several targets and drugs were discovered along this line. We also provide a genotype-based drug reference map using LEGO-based drug screen. This study provides new human GBM models and a research path toward effective GBM therapy.
000287296 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000287296 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000287296 7001_ $$aSun, Meng$$b1
000287296 7001_ $$0P:(DE-He78)7e77b1ec44a0797f186de678c66f80a0$$aShao, Chunxuan$$b2
000287296 7001_ $$aSchlicker, Lisa$$b3
000287296 7001_ $$0P:(DE-He78)24e61e2f659895c9e6d595647a29bf36$$aZhuo, Yue$$b4$$udkfz
000287296 7001_ $$0P:(DE-He78)044b8e7cc52bce80fe9afd70f8f4d44e$$aHarim, Yassin$$b5$$udkfz
000287296 7001_ $$aPeng, Tianping$$b6
000287296 7001_ $$0P:(DE-He78)013c1f7493419ce6a1a10fd28abb172b$$aTian, Weili$$b7$$udkfz
000287296 7001_ $$0P:(DE-He78)79d514e9270d1a0c8b17992db50542f1$$aStöffler, Nadja$$b8$$udkfz
000287296 7001_ $$0P:(DE-He78)0d37cc734b95fed555f2244d6fee6320$$aSchneider, Martin$$b9$$udkfz
000287296 7001_ $$0P:(DE-He78)daaed5a5b968028e6e95d273150d5ab1$$aHelm, Dominic$$b10$$udkfz
000287296 7001_ $$aChu, Youjun$$b11
000287296 7001_ $$aFu, Beibei$$b12
000287296 7001_ $$aJin, Xiaoliang$$b13
000287296 7001_ $$0P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46$$aMallm, Jan-Philipp$$b14$$udkfz
000287296 7001_ $$0P:(DE-He78)cb70d67b37a3b9239e352b7fbead37f5$$aMall, Moritz$$b15$$udkfz
000287296 7001_ $$aWu, Yonghe$$b16
000287296 7001_ $$0P:(DE-He78)94ae391f53fb9285e1b68f9930615af1$$aSchulze, Almut$$b17$$udkfz
000287296 7001_ $$0P:(DE-He78)76aeb2431f7458c9261e69c5420390c6$$aLiu, Haikun$$b18$$eLast author$$udkfz
000287296 773__ $$0PERI:(DE-600)2891458-2$$a10.1038/s41698-024-00500-5$$gVol. 8, no. 1, p. 19$$n1$$p19$$tnpj precision oncology$$v8$$x2397-768X$$y2024
000287296 8564_ $$uhttps://inrepo02.dkfz.de/record/287296/files/s41698-024-00500-5.pdf
000287296 8564_ $$uhttps://inrepo02.dkfz.de/record/287296/files/s41698-024-00500-5.pdf?subformat=pdfa$$xpdfa
000287296 8767_ $$8SN-2024-00420-b$$92024-05-28$$d2025-04-14$$eAPC$$jZahlung erfolgt
000287296 909CO $$ooai:inrepo02.dkfz.de:287296$$pVDB$$pOpenAPC$$popenCost
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)be724b82903aa397737196d8200edb30$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7e77b1ec44a0797f186de678c66f80a0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)24e61e2f659895c9e6d595647a29bf36$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)044b8e7cc52bce80fe9afd70f8f4d44e$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)013c1f7493419ce6a1a10fd28abb172b$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79d514e9270d1a0c8b17992db50542f1$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0d37cc734b95fed555f2244d6fee6320$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)daaed5a5b968028e6e95d273150d5ab1$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)cb70d67b37a3b9239e352b7fbead37f5$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)94ae391f53fb9285e1b68f9930615af1$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000287296 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)76aeb2431f7458c9261e69c5420390c6$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000287296 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000287296 9141_ $$y2024
000287296 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNPJ PRECIS ONCOL : 2022$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T15:13:05Z
000287296 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T15:13:05Z
000287296 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-04-12T15:13:05Z
000287296 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-04-12T15:13:05Z
000287296 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNPJ PRECIS ONCOL : 2022$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-27
000287296 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-27
000287296 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000287296 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000287296 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
000287296 915pc $$0PC:(DE-HGF)0003$$2APC$$aDOAJ Journal
000287296 9202_ $$0I:(DE-He78)A240-20160331$$kA240$$lA240 Molekulare Neurogenetik$$x0
000287296 9200_ $$0I:(DE-He78)A240-20160331$$kA240$$lA240 Molekulare Neurogenetik$$x0
000287296 9201_ $$0I:(DE-He78)A240-20160331$$kA240$$lA240 Molekulare Neurogenetik$$x0
000287296 9201_ $$0I:(DE-He78)W120-20160331$$kW120$$lProteomics$$x1
000287296 9201_ $$0I:(DE-He78)W192-20160331$$kW192$$lscOpen Lab$$x2
000287296 9201_ $$0I:(DE-He78)A340-20160331$$kA340$$lA340 NWG Engeneering von Zellidentitäten und Krankheitsmodellen$$x3
000287296 980__ $$ajournal
000287296 980__ $$aVDB
000287296 980__ $$aI:(DE-He78)A240-20160331
000287296 980__ $$aI:(DE-He78)W120-20160331
000287296 980__ $$aI:(DE-He78)W192-20160331
000287296 980__ $$aI:(DE-He78)A340-20160331
000287296 980__ $$aUNRESTRICTED
000287296 980__ $$aAPC